More than seven million additional Americans could get coverage for popular drugs such as Zepbound and Wegovy under the ...

Millions of Americans would be eligible to have costly weight-loss drugs like Wegovy or Ozempic covered by Medicare or ...

The Medicare Annual Election Period (AEP) is a critical time for beneficiaries to review and update their coverage. In a ...

The Biden administration is looking to expand access to anti-obesity GLP-1 drugs like Ozempic and Wegovy for people who have ...

Medicare and Medicare Advantage plans are open for new signups and changes during this year's open enrollment period.

Millions more senior citizens and lower-income Americans could obtain coverage for costly anti-obesity drugs under a proposal ...

Joe Biden wants diabetes drugs that aid weight loss and treat obesity, such as Wegovy, to fall under Medicare and Medicaid.

The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.

Seven lobbyists and executives who work with top pharmaceutical and biotech companies told Reuters they are pushing to delay ...

The proposal would expand coverage of anti-obesity drugs to 7.5 million people covered by Medicare and Medicaid, the Biden ...

Several healthcare provider networks in Minnesota are choosing not to accept specific Medicare Advantage plans in 2025 due to ...

According to CMS estimates, passage of the rule would open access to the weight-loss medications to 3.4 million potential new ...